SCHEDULE 13G: Goldman Sachs Discloses 7.7% Passive Stake in Definitive Healthcare Corp.

The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have reported a passive beneficial ownership of 7.7% in Definitive Healthcare Corp.'s common stock as of March 31, 2025.

Summary

• The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC have filed a Schedule 13G, indicating their beneficial ownership in Definitive Healthcare Corp.
• As of March 31, 2025, the aggregate amount beneficially owned by the reporting persons is 8,711,896 shares of Common Stock.
• This represents 7.7% of the class of Definitive Healthcare Corp.'s common stock.
• The filing indicates shared voting power over 8,692,700 shares and shared dispositive power over 8,693,876 shares.
• The ownership is held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual regulatory filing disclosing beneficial ownership and does not contain information that would inherently suggest positive or negative sentiment regarding the issuer's performance or prospects.

Positives

• A major financial institution like Goldman Sachs holding a significant stake can be seen as a vote of confidence in Definitive Healthcare Corp.
• The filing indicates a passive investment, suggesting no immediate intent to influence company control, which can provide stability.

Negatives

• The filing itself does not contain negative financial or operational information about Definitive Healthcare Corp.; it is purely an ownership disclosure.

Risks

• The document does not explicitly mention risks related to Definitive Healthcare Corp.'s business operations or financial health, as it is solely a disclosure of beneficial ownership.

Future Outlook

The document is a beneficial ownership filing and does not contain forward-looking statements or guidance regarding Definitive Healthcare Corp.'s future performance or operations.

Management Comments

• The document does not contain direct quotes or paraphrased statements from Definitive Healthcare Corp.'s management. It contains certifications from Goldman Sachs' attorney-in-fact stating the securities were acquired and held in the ordinary course of business and not for control purposes.

Industry Context

This filing indicates a significant institutional investment in the healthcare technology sector, specifically in Definitive Healthcare Corp., a provider of healthcare commercial intelligence. Such investments reflect ongoing interest from major financial players in data-driven healthcare solutions.

Comparison to Industry Standards

• This Schedule 13G filing is a standard regulatory disclosure for institutional investors acquiring a significant passive stake (over 5%) in a public company. It does not provide performance metrics for comparison to industry standards or specific comparable companies/projects, as its purpose is solely to report beneficial ownership.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional investor like Goldman Sachs holding a 7.7% stake may be viewed positively, potentially increasing investor confidence and liquidity. However, as a passive stake, it does not imply active management influence.

Next Steps

• The document does not specify any future actions, events, or milestones for Definitive Healthcare Corp. or the reporting persons beyond the regulatory filing itself.

Key Dates

Keywords

Definitive Healthcare Corp, Goldman Sachs, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Passive Investment, Healthcare Technology